Showing results (31-40 of 285) with videos related to
Sort By:
Pageof 29
Annals of the Rheumatic Diseases|November 18, 2004
HLA-DMA*0103 and HLA-DMB*0104 alleles as novel prognostic factors in rheumatoid arthritisJ Morel, F Roch-Bras, N Molinari, et al.The Journal of Rheumatology|September 1, 1991
Treatment of rheumatoid arthritis with methotrexate: a prospective open longterm study of 191 casesJ Sany, J M Anaya, V Lussiez, et al.Journal of Autoimmunity|December 10, 1999
Intracytoplasmic Th1 and Th2 cytokines in rheumatoid arthritis blood and synovial tissueV Bourg, P Portalès, S Fiorito, et al.Arthritis and Rheumatism|September 1, 1992
IX 207-887 in rheumatoid arthritis. A double-blind placebo-controlled studyM Dougados, B Combe, T Beveridge, et al.Arthritis and Rheumatism|May 1, 1986
Characterization of an expanded subpopulation of large granular lymphocytes in a patient with rheumatoid arthritisB Combe, M Andary, J Caraux, et al.Arthritis and Rheumatism|April 1, 1990
T cell receptor expression and activation of synovial lymphocyte subsets in patients with rheumatoid arthritis. Phenotyping of multiple synovial sitesT Rème, M Portier, F Frayssinoux, et al.British Journal of Rheumatology|June 1, 1995
Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damageB Combe, J F Eliaou, J P Daurès, et al.The Journal of Rheumatology|September 1, 1988
Rheumatoid nodulosis: report of two new cases and discussion of diagnostic criteriaM Couret, B Combe, V T Chuong, et al.European Journal of Clinical Pharmacology|January 1, 1996
A limited sampling method to estimate methotrexate pharmacokinetics in patients with rheumatoid arthritis using a Bayesian approach and the population data modeling program P-PHARMF Bressolle, C Bologna, L Edno, et al.Scandinavian Journal of Immunology|February 1, 1992
Analysis of monoclonal rheumatoid factors obtained from the B-cell repertoire in rheumatoid arthritisM Abderrazik, M Moynier, R Jefferis, et al.Pageof 29